Medical News

RSS

KRG Capital Partners sells ATI Holdings to GTCR Golder Rauner

KRG Capital Partners, a Denver-based buyout firm, completed its sale of ATI Holdings (“ATI”) to GTCR Golder Rauner LLC (“GTCR”). The transaction closed on March 12, 2010. The all cash sale represents KRG’s first full exit in its $715 million Fund III. ATI is a provider of outpatient physical therapy services with an offering that includes physical rehabilitation, hand therapy, aquatic therapy, work conditioning/work hardening, sports medicine and functional capacity assessments.

16 Mar 2010

Novavax reports net loss of $14M for fourth-quarter of 2009

StockPreacher.com announces an investment report featuring Novavax Inc. (Nasdaq:NVAX). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

16 Mar 2010

MDS reports revenues of $46M for first-quarter fiscal 2010

MDS Inc., a leading provider of products and services to the global health science markets, today reported financial results and filed its unaudited interim consolidated financial statements and related Management Discussion & Analysis for the three months ended January 31, 2010. In order to simplify our disclosures, we have discontinued the use of non-GAAP measures such as adjusted EBITDA.

16 Mar 2010

HealthyKidsMN.org Web site launched

The Minnesota Coalition for Kids Health Coverage today announced the launch of HealthyKidsMN.org, a statewide resource that aims to connect families with uninsured children to non-profit agencies that can assist them with eligibility requirements and enrollment into state-sponsored health care coverage options.

16 Mar 2010

Promedior raises $12M in Series C financing

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.

16 Mar 2010

A.D.A.M.'s license revenues increase by 5% for fourth-quarter ended December 31, 2009

A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the fourth quarter ended December 31, 2009.

16 Mar 2010

Aging and Alzheimer's disease: Novel brain imaging technologies help create new insights

The emergence of multiple new brain imaging technologies and the combined application of these new approaches is helping to create new insights into aging and Alzheimer's disease. One of the hallmarks of Alzheimer's disease is the deposition of amyloid beta protein in clumps or "plaques" within the brain. These plaques can be measured in humans with PET scans that use a chemical marker or radiotracer called 11C-PIB.

16 Mar 2010

BeaconEquity.com announces investment report featuring Intellipharmaceutics International

BeaconEquity.com announces an investment report featuring Intellipharmaceutics International Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

16 Mar 2010

Mortality in CAD patients: Key predictor identified

Coronary Artery Disease (CAD) hospitalizes more than 160,000 Canadians every year, and almost one quarter of those patients die from this common form of heart disease. But now a team of Vancouver-based researchers has identified a key predictor of mortality in CAD patients, which means that specialists can better determine how to treat and improve outcomes for patients with CAD.

16 Mar 2010

Itamar, Roche sign agreement to use EndoPAT device in phase II study for patients with PAD

Itamar announced today that it signed an agreement with Roche for use of Itamar’s EndoPAT device in a clinical phase II study for patients with Peripheral Arterial Disease (PAD) at 80 worldwide medical centers.

16 Mar 2010

ICON opens new office in Manila, Philippines

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it will expand its footprint in Asia-Pacific with the opening of an office in Manila, Philippines.

16 Mar 2010

'Molecular band-aid' may help protect hearts of Duchenne muscular dystrophy patients

Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients - a fatal and most common form of muscular dystrophy in children.

16 Mar 2010

BeaconEquity.com: STEM losses $5.2M in fourth-quarter of 2009

BeaconEquity.com announces an investment report featuring biotech company StemCells Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

16 Mar 2010

First Edition: March 16, 2010

In today's headlines, ongoing efforts by President Obama and Democratic leaders to press and persuade wavering votes in support of health reform take center stage.

16 Mar 2010

Enrollment in patient study to evaluate Magellan DART System for Annular Repair completed

Magellan Spine Technologies, Inc. today announced it had completed enrollment in a twenty patient study to evaluate the Magellan DART (Disc Annular Repair Technology) System for Annular Repair following lumbar discectomy procedures. This first study demonstrates evidence that the DART technology is safe and patients implanted with the DART have excellent outcomes approaching one year follow-up.

16 Mar 2010

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty, according to a new Mayo Clinic study. The study was undertaken as a quality control initiative to reduce the potential radiation risks of cancer to patients and PCI operators.

16 Mar 2010

Toshiba displays new, advanced ultrasound systems at ACC annual meeting

Health care facilities use ultrasound as a first-line diagnostic exam to quickly and efficiently perform a range of patient exams, including cardiac imaging. Developed to meet these demanding clinical needs, Toshiba America Medical Systems, Inc. will showcase the advanced cardiac capabilities of its AplioTM MX and Aplio ArtidaTM ultrasound systems at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14-16, 2010 (Booth #1944). This is the first appearance of the Aplio MX at ACC.

16 Mar 2010

Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.

16 Mar 2010

Workings of IGFs on muscle cells

The muscle-building abilities of hormones known as insulin-like growth factors (IGFs) are legendary. Just do an online search and you'll find not only scientific papers discussing the effects of IGFs on the cells that give rise to muscle tissue, but also scores of ads touting the purported benefits of IGF supplements for bodybuilding.

16 Mar 2010

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology announced today that it has received a $4.395 million award from the Defense Advanced Research Projects Agency to develop a vaccine against H1N1 influenza virus using its plant-based production platform.

16 Mar 2010

Medical News

KRG Capital Partners sells ATI Holdings to GTCR Golder Rauner

Novavax reports net loss of $14M for fourth-quarter of 2009

MDS reports revenues of $46M for first-quarter fiscal 2010

HealthyKidsMN.org Web site launched

Promedior raises $12M in Series C financing

A.D.A.M.'s license revenues increase by 5% for fourth-quarter ended December 31, 2009

Aging and Alzheimer's disease: Novel brain imaging technologies help create new insights

BeaconEquity.com announces investment report featuring Intellipharmaceutics International

Mortality in CAD patients: Key predictor identified

Itamar, Roche sign agreement to use EndoPAT device in phase II study for patients with PAD

ICON opens new office in Manila, Philippines

'Molecular band-aid' may help protect hearts of Duchenne muscular dystrophy patients

BeaconEquity.com: STEM losses $5.2M in fourth-quarter of 2009

First Edition: March 16, 2010

Enrollment in patient study to evaluate Magellan DART System for Annular Repair completed

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Toshiba displays new, advanced ultrasound systems at ACC annual meeting

Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

Workings of IGFs on muscle cells

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News